Analyzing Auna (NYSE:AUNA) and Biocorrx (OTCMKTS:BICX)

Biocorrx (OTCMKTS:BICX) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Risk & Volatility

Biocorrx has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, Auna has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Earnings & Valuation

This table compares Biocorrx and Auna”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biocorrx	$800,000.00	10.20	-$3.44 million	($0.16)	-1.72
Auna	$1.23 billion	0.32	$27.39 million	$0.26	20.21

Auna has higher revenue and earnings than Biocorrx. Biocorrx is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Biocorrx and Auna’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biocorrx	N/A	N/A	-73.40%
Auna	1.53%	16.25%	4.03%

Analyst Ratings

This is a breakdown of current ratings for Biocorrx and Auna, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biocorrx	0	1	0	0	2.00
Auna	1	2	1	1	2.40

Auna has a consensus target price of $6.97, indicating a potential upside of 32.57%. Given Auna’s stronger consensus rating and higher probable upside, analysts plainly believe Auna is more favorable than Biocorrx.

Summary

Auna beats Biocorrx on 12 of the 13 factors compared between the two stocks.

About Biocorrx

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.